ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,052.04
0.67%
US Tech 100
17,020.00
0.94%
다우존스 지수
38,144.97
0.64%
Bitcoin
58,975.03
1.27%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Agile Therapeutics Inc (AGRX)

  7. Agile Therapeutics Inc (AGRX) 뉴스

AGRX Agile Therapeutics Inc

0.6022
0.00 (0.00%)
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Agile Therapeutics Inc AGRX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 0.6022 09:00:00
개장가 저가 고가 종가 전일 종가
0.6022
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
28/03/202421:05GLOBEAgile Therapeutics Reports Fourth Quarter & Full Year 2023..
26/03/202405:30GLOBEAgile Therapeutics Announces Delisting from Nasdaq
21/03/202419:35GLOBECorrection - Agile Therapeutics to Report Fourth Quarter and..
20/03/202421:15GLOBEAgile Therapeutics to Report Fourth Quarter and Full Year..
13/03/202420:31GLOBEAgile Therapeutics Completes Pay-off of Debt and Remains..
24/02/202406:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/02/202406:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/02/202423:01GLOBEAgile Therapeutics Announces Exercise of Warrants for $4.8..
16/02/202406:45EDGAR2Form 8-K - Current report
16/02/202406:30GLOBEAgile Therapeutics Announces Extension Granted by Nasdaq..
14/02/202410:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202406:51EDGAR2Form S-1/A - General form for registration of securities..
07/02/202400:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/02/202423:21EDGAR2Form S-1/A - General form for registration of securities..
03/02/202406:27EDGAR2Form S-1/A - General form for registration of securities..
23/01/202423:29GLOBEThe Biden-Harris Administration Announces New Guidance to..
20/12/202322:00EDGAR2Form S-1/A - General form for registration of securities..
12/12/202322:01GLOBEAgile Therapeutics Provides Update on Actions Being Taken to..
12/12/202307:30EDGAR2Form S-1 - General form for registration of securities under..
06/12/202322:00EDGAR2Form 8-K - Current report
04/12/202322:00EDGAR2Form 8-K - Current report
10/11/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:15EDGAR2Form 8-K - Current report
09/11/202322:05GLOBEAgile Therapeutics Reports Third Quarter 2023 Financial..
26/10/202321:05GLOBEAgile Therapeutics to Report Third Quarter 2023 Financial..
05/10/202305:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202305:30GLOBEAgile Therapeutics Reports an Inducement Grant to New Chief..
03/10/202305:30EDGAR2Form 8-K - Current report
29/09/202305:50EDGAR2Form 8-K - Current report
05/09/202321:05GLOBEAgile Therapeutics to Present at the H.C. Wainwright 25th..
26/08/202305:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/08/202321:30EDGAR2Form 8-K/A - Current report: [Amend]
10/08/202305:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202321:10EDGAR2Form 8-K - Current report
09/08/202321:05GLOBEAgile Therapeutics Reports Second Quarter 2023 Financial..
26/07/202321:30GLOBEAgile Therapeutics to Report Second Quarter 2023 Financial..
01/07/202305:50EDGAR2Form 8-K - Current report
01/07/202305:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/07/202305:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/07/202305:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/07/202305:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/07/202305:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/06/202321:01GLOBEAgile Therapeutics Announces the Availability of Twirla® to..
24/06/202301:05GLOBEAgile Therapeutics Commends the Biden Administration’s..
16/06/202305:05GLOBEAgile Therapeutics Announces the Availability of Twirla®..
14/06/202305:05GLOBEAgile Therapeutics Announces New Agreement with vitaCare®..
26/05/202305:05GLOBEAgile Therapeutics Announces Closing of $7.5 Million Public..
23/05/202309:00GLOBEAgile Therapeutics Announces Pricing of $7.5 Million Public..
12/05/202305:05GLOBEAgile Therapeutics Reports First Quarter 2023 Financial..
08/05/202321:00GLOBEAgile Therapeutics to Report First Quarter 2023 Financial..

최근 히스토리

NASDAQ
AGRX
Agile Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유